[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-31710":3,"doc-seo-31710":27},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":4,"is_deleted":4,"is_public":19,"is_downloadable":19,"audit_status":19,"page_count":20,"language":21,"language_code":22,"table_of_contents":23,"faqs":24,"seo_title":13,"seo_description":14,"update_tm":25,"read_time":26},31710,2336464648322,"Aria","https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488",8,"Research & Report","Bioprocessing of Inclusion Bodies from E Coli to Produce Bioactive Proteins","Escherichia coli is widely used to produce biotherapeutic proteins that do not require complex glycosylation, but high expression often drives recombinant proteins into inclusion bodies (IBs), which are inactive and misfolded. Production, solubilization, and refolding require process optimization across physical, chemical, and biological parameters to recover functional protein efficiently. The review analyzes upstream and downstream challenges, emphasizing how IB-based workflows can improve yield and simplify purification while addressing economic bottlenecks in high-density fermentation and purification throughput.","cbCainTUA1xF6z4e","https://ap.wps.com/l/cbCainTUA1xF6z4e","pdf",1425337,1,12,"English","en","# Introduction\n## Bioprocessing of IBs\n## Upstream processing aspect for IBs\n### Production of IBs","[{\"question\":\"Why are inclusion bodies (IBs) important in E. coli biotherapeutic protein production?\",\"answer\":\"E. coli overexpression can cause proteins to form inactive, misfolded IBs. Despite this, IBs can be stable, allow high titers, and simplify isolation, reducing purification needs in some workflows.\"},{\"question\":\"Which parameter categories are commonly optimized to obtain functionally active proteins from IBs?\",\"answer\":\"Optimization is grouped into physical parameters (e.g., temperature, pH, feed flow rate), chemical parameters (e.g., feed, dissolved oxygen, IPTG), and biological parameters (e.g., expression vectors and E. coli strain).\"},{\"question\":\"What are the main bottlenecks addressed in the bioprocessing of IB-derived proteins?\",\"answer\":\"High cell density fermentation and high throughput purification of recombinant proteins from IBs are identified as the primary bottlenecks for economical production.\"}]",1780002063,30,{"code":4,"msg":28,"data":29},"ok",{"site_id":30,"language":22,"slug":31,"title":13,"keywords":32,"description":14,"schema_data":33,"social_meta":84,"head_meta":86,"extra_data":88,"updated_unix":25},105,"bioprocessing-of-inclusion-bodies-from-e-coli-to-produce-bioactive-proteins","",{"@graph":34,"@context":83},[35,52,66],{"@type":36,"itemListElement":37},"BreadcrumbList",[38,42,46,49],{"item":39,"name":40,"@type":41,"position":19},"https://docshare.wps.com","Home","ListItem",{"item":43,"name":44,"@type":41,"position":45},"https://docshare.wps.com/document/","Document",2,{"item":47,"name":12,"@type":41,"position":48},"https://docshare.wps.com/document/research-report/",3,{"item":50,"name":13,"@type":41,"position":51},"https://docshare.wps.com/document/bioprocessing-of-inclusion-bodies-from-e-coli-to-produce-bioactive-proteins/31710/",4,{"url":50,"name":13,"@type":53,"author":54,"headline":13,"publisher":56,"fileFormat":59,"description":14,"dateModified":60,"datePublished":60,"encodingFormat":59,"isAccessibleForFree":61,"interactionStatistic":62},"DigitalDocument",{"name":9,"@type":55},"Person",{"url":39,"name":57,"@type":58},"DocShare","Organization","application/pdf","2026-05-28",true,{"@type":63,"interactionType":64,"userInteractionCount":4},"InteractionCounter",{"@type":65},"ViewAction",{"@type":67,"mainEntity":68},"FAQPage",[69,75,79],{"name":70,"@type":71,"acceptedAnswer":72},"Why are inclusion bodies (IBs) important in E. coli biotherapeutic protein production?","Question",{"text":73,"@type":74},"E. coli overexpression can cause proteins to form inactive, misfolded IBs. Despite this, IBs can be stable, allow high titers, and simplify isolation, reducing purification needs in some workflows.","Answer",{"name":76,"@type":71,"acceptedAnswer":77},"Which parameter categories are commonly optimized to obtain functionally active proteins from IBs?",{"text":78,"@type":74},"Optimization is grouped into physical parameters (e.g., temperature, pH, feed flow rate), chemical parameters (e.g., feed, dissolved oxygen, IPTG), and biological parameters (e.g., expression vectors and E. coli strain).",{"name":80,"@type":71,"acceptedAnswer":81},"What are the main bottlenecks addressed in the bioprocessing of IB-derived proteins?",{"text":82,"@type":74},"High cell density fermentation and high throughput purification of recombinant proteins from IBs are identified as the primary bottlenecks for economical production.","https://schema.org",{"og:url":50,"og:type":85,"og:title":13,"og:site_name":57,"og:description":14},"article",{"robots":87,"canonical":50},"index,follow",{"doc_id":7,"site_id":30}]